News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gemmus Pharma Adds Life Science Industry Experts to Board of Directors


8/1/2012 10:35:48 AM

SAN FRANCISCO--(BUSINESS WIRE)--Gemmus Pharma Inc. a privately held biotechnology company developing an improved host-targeted treatment for flu, today announced the appointment of three new directors, Christopher Dunn, M.D. and Louis (Larry) H. Miller Jr., and Independent Director Marc Rubin, M.D. to its Board of Directors.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES